Kolexia
Rusinaru Dan
Cardiologie
Centre Hospitalier D'Amiens Salouël Site Sud
Salouël, France
152 Activités
184 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sténose pathologique Sténose aortique Insuffisance mitrale Défaillance cardiaque Fibrillation auriculaire Maladie des artères coronaires Accident vasculaire cérébral Endocardite Diabète

Industries

Novo Nordisk
2 collaboration(s)
Dernière en 2023
Abbott
1 collaboration(s)
Dernière en 2023
Sanofi
1 collaboration(s)
Dernière en 2023
AstraZeneca
1 collaboration(s)
Dernière en 2023

Dernières activités

Quantifying the Survival Loss Linked to Late Therapeutic Indication in High-Gradient Severe Aortic Stenosis
JACC advances   01 mars 2024
Right Ventricle to Pulmonary Artery Coupling in Severe Aortic Stenosis With Preserved Ejection Fraction.
JACC. Cardiovascular imaging   07 octobre 2023
Response by Essayagh et al to Letter Regarding Article, "The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum".
Circulation   18 septembre 2023
Chronic kidney disease is a key risk factor for aortic stenosis progression.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association   29 mai 2023
Is "moderate" aortic stenosis still the right name? A review of the literature.
Archives of cardiovascular diseases   12 mai 2023
Factors influencing post-surgical survival in degenerative mitral regurgitation.
European heart journal   09 mars 2023
Prognostic Implications of Discordant Low-Gradient Severe Aortic Stenosis: Comprehensive Analysis of a Large Multicenter Registry
JACC advances   01 mars 2023
WCN23-0900 CHRONIC KIDNEY DISEASE IS A KEY RISK FACTOR FOR AORTIC STENOSIS PROGRESSION
ISN World Congress of Nephrology (WCN) 2023 Abstracts   01 mars 2023
The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum.
Circulation   27 décembre 2022
Effect of frailty on survival after cardiac resynchronization therapy.
Archives of cardiovascular diseases   29 septembre 2022